Sibutramine for weight gain attenuation during smoking cessation with varenicline: A pilot study

Nicotine and Tobacco Research

Volumn 11, Issue 12, 2009, Pages 1479-1484

  Sood, Amit ^a   Ebbert, Jon O ^a   Clark, Matthew M ^a   Croghan, Ivana T ^a   Schroeder, Darrell R ^a   Hays, J Taylor ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIBUTRAMINE; VARENICLINE;

ABSTINENCE; ARTICLE; BODY WEIGHT DISORDER; CLINICAL ARTICLE; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INSOMNIA; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SATISFACTION; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO DEPENDENCE; VIVID DREAM; WEIGHT CHANGE; WEIGHT GAIN;

ADULT; APPETITE DEPRESSANTS; BENZAZEPINES; CYCLOBUTANES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; NICOTINIC AGONISTS; PATIENT DROPOUTS; PILOT PROJECTS; QUINOXALINES; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; WEIGHT GAIN; YOUNG ADULT;

EID: 70849135779     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntp162     Document Type: Article

References (32)

1. Biener, L., & Abrams, D. B. (1991). The contemplation ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology, 10, 360-365.
2. Borrelli, B., & Mermelstein, R. (1998). The role of weight concern and self-efficacy in smoking cessation and weight gain among smokers in a clinic-based cessation program. Addictive Behaviors, 23, 609-622.
3. Cash, T. F., & Pruzinsky, T. (1990). Body images: Development, deviance, and change. New York: Guildford Press.
4. Cassels, S. (2006). Overweight in the Pacific: Links between foreign dependence, global food trade, and obesity in the Federated States of Micronesia. Global Health, 2, 10.
5. Chhatwal, J., Verma, M., & Riar, S. K. (2004). Obesity among pre-adolescent and adolescents of a developing country (India). Asia Pacific Journal of Clinical Nutrition, 13, 231-235.
6. Clark, M. M., Abrams, D. B., Niaura, R. S., Eaton, C. A., & Rossi, J. S. (1991). Self-efficacy in weight management. Journal of Consulting and Clinical Psychology, 59, 739-744.
7. Clark, M. M., Croghan, I. T., Reading, S., Schroeder, D. R., Stoner, S. M., Patten, C. A., et al. (2005). The relationship of body image dissatisfaction to cigarette smoking in college students. Body Image, 2, 263-270.
8. Clark, M. M., Hays, J. T., Vickers, K. S., Patten, C. A., Croghan, I. T., Berg, E., et al. (2005). Body image treatment for weight concerned smokers: A pilot study. Addictive Behaviors, 30, 1236-1240.
9. French, S., & Jeffery, R. (1995). Weight concerns and smoking: A literature review. Annals of Behavioral Medicine, 1 7, 234-244.
10. Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulay, S., Billing, C. B., et al. (2006). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 47-55.
11. Granner, M. L., Black, D. R., & Abood, D. A. (2002). Levels of cigarette and alcohol use related to eating-disorder attitudes. American Journal of Health Behavior, 26, 43-55.
12. Gregg, E. W., Cheng, Y. J., Cadwell, B. L., Imperatore, G., Williams, D. E., Flegal, K. M., et al. (2005). Secular trends in cardiovascular disease risk factors according to body mass index in US adults. Journal of the American Medical Association, 293, 1868-1874.
13. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
14. Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003). Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research, 5, 13-25.
15. Jeffery, R. W., Hennrikus, D. J., Lando, H. A., Murray, D. M., & Liu, J. W. (2000). Reconciling conflicting findings regarding postcessation weight concerns and success in smoking cessation. Health Psychology, 19, 242-246.
16. Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J., Williams, K. E., et al. (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296 56-63.
17. King, T. K., Matacin, M., Marcus, B. H., Bock, B. C., & Tripolone, J. (2000). Body image evaluations in women smokers. Addictive Behaviors, 25, 613-618.
18. King, T. K., Matacin, M., White, K. S., & Marcus, B. H. (2005). A prospective examination of body image and smoking cessation in women. Body Image, 2, 19-28.
19. Kuehn, B. M. (2009). Varenicline gets stronger warnings about psychiatric problems, vehicle crashes. Journal of the American Medical Association, 302, 834.
20. Mendez, M. A., Monteiro, C. A., & Popkin, B. M. (2005). Overweight exceeds underweight among women in most developing countries. American Journal of Clinical Nutrition, 81, 714-721.
21. Meyers, A. W., Klesges, R. C., Winders, S. E., Ward, K. D., Peterson, B. A., & Eck, L. H. (1997). Are weight concerns predictive of smoking cessation? A prospective analysis. Journal of Consulting and Clinical Psychology, 65, 448-452.
22. Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006). Prevalence of overweight and obesity in the United States, 1999-2004. Journal of the American Medical Association, 295, 1549-1555.
23. O'Hara, P., Connett, J. E., Lee, W. W., Nides, M., Murray, R., & Wise, R. (1998). Early and late weight gain following smoking cessation in the Lung Health Study. American Journal of Epidemiology, 148, 821-830.
24. Parsons, A. C., Shraim, M., Inglis, J., Aveyard, P., & Hajek, P. (2009). Interventions for preventing weight gain after smoking cessation. Cochrane Database of Systematic Reviews, (1), CD006219.
25. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
26. Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. (2007). Long term pharmacotherapy for obesity and overweight: Updated meta-analysis. British Medical Journal, 335, 1194-1199.
27. Sturm, R. (2007). Increases in morbid obesity in the USA: 2000-2005. Public Health, 121, 492-496.
28. Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., et al. (2006). Heart disease and stroke statistics - 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 113, e85-e151.
29. Van Gaal, L. F., Wauters, M. A., & De Leeuw, I. H. (1998). Antiobesity drugs: What does sibutramine offer? An analysis of its potential contribution to obesity treatment. Experimental and Clinical Endocrinology and Diabetes, 106 (Suppl. 2), 35-40.
30. Vazquez Roque, M. I., Camilleri, M., Clark, M. M., Tepoel, D. A., Jensen, M. D., Graszer, K. M., et al. (2007). Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clinical Gastroenterology and Hepatology, 5 829-837.
31. Williams, D. M., Lewise, B. A., Dunsiger, S. M., & Bess, H. (2005). The effect of moderate intensity exercise on smoking cessation. Medicine and Science in Sports and Exercise, 37, 1-2.
32. World Health Organization. (2002). Smoking statistics, Retrieved 27 May 2008, from http://www.wpro.who.int/media_centre/fact_sheets/ fs_20020528.htm